(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OMNICATHEPSIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OMNICATHEPSIN

ST13

US500000085367246

Class

1

Filing

85367246

Registration

4124847

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

10/21/2022

Trademark type

Word

Nice classes

1

Filing date

07/09/2011

Registration date

04/10/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/05/2022

Last transaction

10/21/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

06/15/1999

First use in commerce

06/15/1999

Drawing code

4

Owner type

03

Owner location

Farmingdale, NY, US

Examiner

AWRICH, ELLEN

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Enzo Life Sciences, Inc.

Representatives

Joel E. Tragesser Quarles & Brady LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Fluorogenic peptide substrate for scientific research use

Publications

History of USPTO decisions and trademark events.

34 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/05/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/05/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/05/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/05/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/26/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/26/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/26/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

04/09/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/10/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/05/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/05/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/05/2018

E815

TEAS SECTION 8 & 15 RECEIVED

01/20/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/10/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/26/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

04/10/2012

PUBO

PUBLISHED FOR OPPOSITION

01/24/2012

NPUB

NOTICE OF PUBLICATION

01/04/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/20/2011

ALIE

ASSIGNED TO LIE

12/19/2011

CNEA

EXAMINERS AMENDMENT MAILED

11/29/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/28/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

11/28/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/28/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/23/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/23/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/23/2011

CNRT

NON-FINAL ACTION MAILED

10/18/2011

CNRT

NON-FINAL ACTION WRITTEN

10/17/2011

DOCK

ASSIGNED TO EXAMINER

10/14/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2011

NWAP

NEW APPLICATION ENTERED

07/13/2011

Continuous trademark protection

Get notified about every new filing that threatens OMNICATHEPSIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.